Safe and effective topical application dose of lidocaine for surgery with laryngomicroscopy

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 2, 1996, Pages 229-235

  Kotaki, Hajime ^a   Tayama, Nirou ^b   Ito, Kiyomi ^b   Mitomi, Natsuhiko ^b   Tezuka, Katsuhiko ^b   Kaga, Kimitaka ^b   Sawada, Yasufumi ^b   Iga, Tatsuji ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; HUMAN; LARYNGOSCOPY; LOCAL ANESTHESIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANESTHETICS, LOCAL; FEMALE; HUMANS; LARYNGOSCOPY; LIDOCAINE; MALE; MIDDLE AGED; OROPHARYNX; SEIZURES;

EID: 0029958204     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90139-3     Document Type: Article

References (15)

1. Pieper JA, Johnson KE. Lidocaine. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics. San Francisco: Applied Pharmacokinetics, 1990:21-37.
2. Buckman K, Claiborne K, Guzman M, Walberg CB, Haywood LJ. Lidocaine efficacy and toxicity assessed by a new, rapid method. Clin Pharmacol Ther 1980; 28:177-81.
3. Gianelly R, Groeben JO, Spivack AP, Harrison DC. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med 1967;277:1215-9.
4. Wu FL, Razzaghi A, Souney PF. Seizure after lidocaine for bronchoscopy: case report and review of the use of lidocaine in airway anesthesia. Pharmacotherapy 1993;13:72-8.
5. Fruncillo RJ, Gibbons W, Bowman SM. CNS toxicity after ingestion of topical lidocaine. N Engl J Med 1985;306:426-7.
6. Parish RC, Moor RT, Gotz VP. Seizures following oral lidocaine for esophageal anesthesia. Drug Intell Clin Pharm 1985;19:199-201.
7. Rothstein P, Dornbusch J, Shaywitz BA. Prolonged seizures associated with the use of viscous lidocaine. J Pediatr 1982;101:461-3.
8. Giard MJ, Uden DL, Whitlock DJ, Watson DM. Seizures induced by oral viscous lidocaine [letter]. Clin Pharm 1983;2:110.
9. Mofenson HC, Caraccio TR, Miller H, Greensher J. Lidocaine toxicity from topical mucosal application: with a review of the clinical pharmacology of lidocaine. Clin Pediatr 1983;22:190-2.
10. Xylocaine product information. In: Physician's desk reference. 49th ed. Montvale, NJ: Medical Economics, 1995:580-2.
11. Ritchie JM, Greene NM, Local anesthetics. In: Goodman LS, Gilman A, Rail TW, Murad F, editors. The pharmaceutical basis of therapeutics. 7th ed. New York: Macmillan, 1985:303-21.
12. Thomson PD, Melmon KL, Richardson JA, Cohn K, Steinbrunn W, Cudihee R, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease and renal disease in humans. Ann Intern Med 1973;78: 499-508.
13. Forrest JA, Finlayson NDC, Adjepon-Yamoah KK, Prescott LF. Antipyryne, paracetamol and lidocaine elimination in chronic liver disease. Br Med J 1977;1: 1384-7.
14. Nations RL, Triggs EJ, Seling M. Lignocaine kinetics in cardiac and aged subjects. Br J Clin Pharmacol 1977;4:439-48.
15. Keenaghan JB, Boyes RN. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pig, dogs and man. J Pharmacol Exp Ther 1962;180: 454-63.